Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2020

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS

(Dollars in millions)

			Additions
	Balance at beginning of period		Charged to costs and expenses		Charged to other accounts			Deductions			Translations		Balance at end of period
Year Ended December 31, 2020
Allowance for doubtful accounts	$	8.5	$	0.4	$	—		$	—		$	(0.5)	$	8.4
Allowance for excess and obsolete inventory	10.6		0.4		—			(0.5)		(3)	(0.8)		9.7
Deferred tax assets valuation allowance	68.2		0.3		—		(1)	(36.6)		(4)	2.0		33.9
Year Ended December 31, 2019
Allowance for doubtful accounts	$	8.1	$	0.2	$	—		$	—	(2)	$	0.2	$	8.5
Allowance for excess and obsolete inventory	8.9		10.0		—			(8.0)		(3)	(0.3)		10.6
Deferred tax assets valuation allowance	65.2		5.4		5.3			(5.9)			(1.8)		68.2
Year Ended December 31, 2018
Allowance for doubtful accounts	$	9.1	$	(0.9)	$	—		$	—	(2)	$	(0.1)	$	8.1
Allowance for excess and obsolete inventory	7.9		8.6		—			(7.4)		(3)	(0.2)		8.9
Deferred tax assets valuation allowance	26.8		38.7		—			—			(0.3)		65.2

_______________

(1)Deferred tax assets valuation allowance related to the VRV acquisition.

(2)Reversal of amounts previously recorded as bad debt and uncollectible accounts written off.

(3)Inventory items written off against the allowance.

(4)Deductions to the deferred tax assets valuation allowance relate to decreased deferred tax assets and the release of the valuation allowance. During the year ended December 31, 2020, we reduced our deferred tax assets relative to the Cryobiological Divestiture and as such also reduced the related valuation allowance by $32.4.